A Real-Time Polymerase Chain Reaction Assay for Rapid, Sensitive, and Specific Quantification of the JAK2V617F Mutation Using a Locked Nucleic Acid-Modified Oligonucleotide

This publication has 41 references indexed in Scilit:

• Concordance of assays designed for the quantification of JAK2V617F: a multicenter study
  Haematologica, 2009
• Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
  Leukemia, 2008
• The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers
  Annals of Hematology, 2007
• Quantitative Determination of JAK2 V617F by TaqMan: An Absolute Measure of Averaged Copies per Cell That May Be Associated with the Different Types of Myeloproliferative Disorders
  The Journal of Molecular Diagnostics, 2007
• Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders
  The Journal of Molecular Diagnostics, 2007
• Development of a Quantitative Real-Time Polymerase Chain Reaction Assay for the Detection of the JAK2 V617F Mutation
  The Journal of Molecular Diagnostics, 2007
• Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2V617F
  Leukemia, 2007
• JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility
  The Journal of Molecular Diagnostics, 2006
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005